Vivo Capital, LLC Regulus Therapeutics Inc. Put Options Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RGLS
# of Institutions
40Shares Held
30.8MCall Options Held
94.1KPut Options Held
4.1K-
Nea Management Company, LLC Timonium, MD6.47MShares$52.8 Million1.07% of portfolio
-
Octagon Capital Advisors LP New York, NY4.64MShares$37.8 Million2.7% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$32.4 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.69MShares$22 Million0.06% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.97MShares$16.1 Million0.01% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $119M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...